Host Mike Moore interviews David Herbada, Chairman of the Board with Spectroma. This deep tech company is developing a completely new modality to facilitate whole body imaging. They hope their Ultra Wide Band Microwave Imaging technology will provide an alternative to CT or MRI that is safely repeatable, less expensive per scan, and will require a much smaller footprint from a form factor perspective. If successful, this technology stands to reimagine Primary Care, and beyond!

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

On this episode host Mike Moore interviews Physician turned Digital Health Founder/CEO, Maria Artunduaga of Samay Health. Maria and her team are building a first in class wearable patch technology (Sylvee™), which they hope will enable remote respiratory monitoring using acoustics to detect and measure trapped air in the lungs.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Host Mike Moore visits w/ Matthieu De Buele, Founder & CEO of FEops. FEops has developed a proprietary cloud-based, AI powered structural heart procedure planning platform (HEARTguide™) that is poised to positively impact outcomes and the economic viability of various Structural Heart procedures. At present the technology can be applied in Left Atrial Appendage & TAVR procedures. The company hopes to add Percutaneous Mitral Valve Replacement, and several additional indications to their offering moving forward.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Mike Moore sits down with Ken Nelson, Chairman of the Board for CardiaCare. CardiaCare is a clinical stage company that is developing what would be a first in class watch-like wearable technology to detect rhythm abnormalities, as well as deliver personalized neuromodulation therapy.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Filip Peters, Co-Founder & CEO of Acorai sits down with host Mike Moore to discuss how he and his team are setting a new standard of care in Heart Failure management. Their AI/ML powered, handheld, non-invasive device is intended to provide HCP's with a scalable solution for managing intracardiac pressures. Their device combines Seismic, Acoustic, Visual, and Electrical (S.A.V.E.) sensors with AI/ML, to generate unique cardiac insights. The company is also developing a proprietary Heart Failure patient management software program which will enable physicians to incorporate this actionable information into their clinical decision making process.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Host Mike Moore sits down with Co-Founder & CEO of Vital, Vasu Nadella. Vasu and his team are reimagining lab testing to enable radically accessible care. The company is striving to make painless, comprehensive, lab grade results available in minutes to patients everywhere. Vital reengineered every component of the diagnostics process, utilizing the latest in robotics, biochemistry, computer vision, and microfluidics, in hopes of creating a new standard of care in lab testing.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Host Mike Moore interviews Co-Founder & CEO of MatchDay Health, Rami Wehbi. MatchDay is building an exclusive online community for doctors, by doctors, helping vetted physicians grow their career opportunities, crowdsource valuable information and connect in a meaningful way. The company’s mission is to help reduce burnout by matching doctors to high-quality, high-paying jobs that lead to a higher quality of life and satisfaction.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health

Host Mike Moore sits down with Co Founder & CEO, Torrey Smith & Chief Business Officer, Chris Green of Endiatx, which is developing robot pills for telemedicine. Ediatx’s first product, PillBot™, is a virtual endoscope or “moving eyeball in the stomach”. It's a pill camera you swallow that lets you access the world's best GI doctors without leaving home. But they are not stopping there!

Building on the PillBot™ platform, Endiatx plans to create additional robotic devices with increasing features and miniaturization. Next will come PillSurgeon™, which will use the PillBot™ platform but add tools to remove polyps, cauterize bleeds, sample the microbiome, and collect biopsy. Beyond this, Endiatx envisions a suite of robotic surgeons of ever-decreasing size and broadening scope of applications within the human body.

Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health